Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

SIRONA BIOCHEM Corporate Update April 2024

GlobeNewswire April 8, 2024

Sirona Biochem Announces Close of Private Placement

GlobeNewswire April 4, 2024

Sirona Biochem Announces 2023 Annual Meeting Results

GlobeNewswire March 28, 2024

Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

GlobeNewswire March 13, 2024

Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim(TM) in Early 2025

GlobeNewswire February 21, 2024

Sirona Biochem Provides Update on Loan

GlobeNewswire February 15, 2024

Sirona Biochem Engages Global Beauty Consulting

GlobeNewswire February 15, 2024

Sirona Biochem Announces Loan

GlobeNewswire January 29, 2024

Sirona Biochem Initiates Private Placement

GlobeNewswire January 26, 2024

CORRECTION -- Sirona Biochem Corporate Update January 2024

GlobeNewswire January 24, 2024

Sirona Biochem Corporate Update January 2024

GlobeNewswire January 24, 2024

Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)

GlobeNewswire January 15, 2024

Sirona Biochem Initiates GlycoProteMim(TM) Trademark for Anti-Aging Molecule TFC-1326

GlobeNewswire December 11, 2023

Sirona Biochem Announces Change of Auditor

GlobeNewswire October 25, 2023

Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares

GlobeNewswire October 20, 2023

Sirona Biochem Corporate Update

GlobeNewswire July 13, 2023

Sirona Biochem advances research for antiviral compounds

Jocelyn Aspa June 28, 2023

Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB

GlobeNewswire June 28, 2023

Sirona Biochem Engages Atheln Inc. to Strengthen Business Development Initiatives

GlobeNewswire May 25, 2023

Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy

GlobeNewswire May 11, 2023